NCT00125593
Study of Heart and Renal Protection
See it on ClinicalTrials.gov ↗9,270 people
37.4%
62.6%
3,470 womenmiddle line = equal numbers5,800 men
- Phase
- PHASE4
- Paid for by
- University of Oxford
- Finished
- 2010-08
- Health conditions
- Kidney Disease, Chronic
- Who could join
- Anyone
- Ages
- 40 Years – no maximum
- Average age
- mean 62 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Child-bearing potential (i.e. premenopausal woman who was not using a reliable method of contraception)”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Definite history of chronic liver disease, or abnormal liver function (i.e. alanine aminotransferase \[ALT\] greater than 1.5 x upper limit of normal \[ULN\] or, if ALT not available, aspartate aminotransferase \[AST\] greater than 1.5 x UL…”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Definite history of myocardial infarction or coronary revascularization procedure”
- No cancer
Women with current or past cancer were turned away.
“…at might have limited the individual's ability to take trial treatments for the duration of the study (e.g. severe respiratory disease, history of cancer other than non-melanoma skin cancer, or recent history of alcohol or substance misuse)”
Study titles and rules are shown in their original English.